期刊文献+

骨髓间质干细胞与肿瘤细胞中FN1、NME2、TIMP3基因表达检测 被引量:5

Detection for expression level of gene FN1,NME2 and TIMP3 in mesenchymal stem cells,tumor cells and leukemia cells
下载PDF
导出
摘要 目的探讨纤维连接蛋白1(FN1)、肿瘤转移抑制基因2(NME2)、组织金属蛋白酶抑制因子3(TIMP3)基因在胎儿骨髓间质干细胞(FMSCs)、成人骨髓间质干细胞(AMSCs)、F6、SGC及白血病细胞中的差异表达,寻找肿瘤和白血病的分子生物学特征。方法分别提取FMSCs、AMSCs、F6、SGC及白血病细胞的总RNA,逆转录cDNA,以cDNA为模板用PCR和实时PCR技术分别测定FN1、NME2、TIMP3基因表达水平。结果AMSCs组FN1、NME2、TIMP3基因表达水平均高于FMSCs、F6、SGC组(P<0.001);F6细胞以及白血病细胞中未能检出TIMP3基因的表达。结论FN1、NME2、TIMP3基因的下调以及TIMP3基因的缺如,可能是FMSCs突变为F6肿瘤细胞的分子特征之一;TIMP3基因的下调可能是肿瘤细胞的一种分子标志。 Objective To investigate the differential expression of genes encoding fibronectin 1 (FNI), non-metastatic cell proteins 2 (NME2) and tissue inhibitor of metalloproteinase 3 (TIMP3) in fetal bone marrow mesenchymal stem cells ( FMSCs), adult bone marrow mesenchymal stem cells (AMSCs), F6, SGC and leukemia cells and study the molecular biological characters of tumor and leukemia cells. Methods RT-PCR was used to clone the cDNA of total RNA extracted from FMSCs, AMSCs, F6, SGC and leukemia cells respectively and then the expression levels of gene FN1, NME2 and TIMP3 were detected by PCR and real-time PCR. Results The expression levels of gene FN1 ,NME2 and TIMP3 in AMSCs were higher than those in FMSCs,F6,SGC (P 〈0. 001 ) ,but gene TIMP3 could not be detected in cDNA of F6 and leukemia cells. Conclusions The down-regulation of gene FN1, NME2 and TIMP3 or the deficiency of gene TIMP3 may be one of the molecular characteristics of the mutation of F6 from FMSCs, and the down-regulation of gene TIMP3 is probably one of the common markers of tumor cells.
出处 《临床检验杂志》 CAS CSCD 北大核心 2006年第2期106-109,共4页 Chinese Journal of Clinical Laboratory Science
基金 国家自然科学基金项目(30471938) 卫生部科学研究基金(WKJ2005-2-204) 江苏大学创新预研基金项目(04CX07) 江苏大学高级人才启动基金项目(04JDG028)
关键词 基因 间质干细胞 F6 白血病 gene mesenchymal stem cells F6 leukemia
  • 相关文献

参考文献15

二级参考文献20

  • 1钱晖,许文荣,张锡然,孙晓春,朱伟,胡嘉波.胚胎骨髓间质干细胞分离纯化及基本生物学特性[J].解剖学报,2004,35(4):440-442. 被引量:7
  • 2许文荣 谷俊侠 主编.临床血液学检验[M].南京:东南大学出版社,2000..
  • 3Pittenger M F, Mackay A M, Beck S C,et al. Multilineage potential of adult human mesenchymal stem cells[J] .Science, 1999,284(.5411) :143-147.
  • 4Rangappa S, Reddy V G, Bongso A, et al. Transformation of the adult human mesenchymal stun cells into cardiomyocyte-like cells in vivo[J].Cardiovascular Engineering 2002,2( 1 ):7-14.
  • 5Wakitani S, Saito T, Caplan A I. Myogenic cells derived from rat bane marrow mesenchymal stem cells exposed to 5-azacytidine, Muscle&Nerve[J]. 1995,18(12) : 1417-1426.
  • 6Devine,S M. Mesenchymal stem cells: will they have a role in the clinic [ J ] ? J Cellular Biochemistry, 2002, 38 (Supplement) : 73-79.
  • 7Studeny M, Marini F C, Champlin R E, et al. Bone marrow-derived mesenehymal stem cells as vehicles for interferon delivery into tumors[J].Cancer Res 2002,62 ( 13 ) : 3603-3608.
  • 8Cesare C,Irene A G, Robert, et al. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow[ J]. Blood, 2001,98(8) :2396-2402.
  • 9Setoguchi T,Taga T,Kondo T.Cancer stem cells persist in many cancer cell lines[J].Cell Cycle,2004,3:414-415.
  • 10Reya T,Morrison S,Clarke M F,et al.Stem cells,cancer,and cancer stem cells[J].Nature,2001,414:105-111.

共引文献40

同被引文献64

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部